Data / Drug companies / Bispit Canada Ltd.
Bispit Canada Ltd.: 12 products in the FDA NDC directory, labeler code 85631
Bispit Canada Ltd. (labeler code 85631) lists 12 products in the FDA National Drug Code Directory, covering 1 finished drug by generic name. By type: 12 over the counter drugs. Its main marketing category is unapproved homeopathic products. The newest product started marketing on January 22, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 85631
- Products in commercial distribution
- 12
- Packages
- 12
- Finished drugs by generic name
- 1
- Prescription products
- 0
- Over the counter products
- 12
- Flagged as original packager
- 12 of 12 products that carry the flag
- Started marketing in the last 12 months
- 3
- Earliest marketing start
- May 6, 2025
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Unapproved homeopathic products | 10 | 83.3% |
| Other unapproved drugs | 2 | 16.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 12 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Reishi yeast fu ling ophiopogon japonicus whole | 2 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 9 | 75% |
| Tablet | 3 | 25% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Non-Standardized Food Allergenic Extract | 11 |
| Non-Standardized Plant Allergenic Extract | 3 |
| Non-Standardized Fungal Allergenic Extract | 3 |
| Osmotic Laxative | 2 |
| Copper Absorption Inhibitor | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Natural uric acid joint comfort supplement 3310b | 85631-019 | Capsule | Unapproved homeopathic products | January 22, 2026 |
| Anti-h.pylori formula | 85631-016 | Capsule | Other unapproved drugs | December 22, 2025 |
| Stomach-soothing formula | 85631-015 | Capsule | Other unapproved drugs | December 22, 2025 |
| Pulmonary Nodule | 85631-011 | Capsule | Unapproved homeopathic products | November 3, 2025 |
| Breast nodule | 85631-010 | Capsule | Unapproved homeopathic products | November 3, 2025 |
| Gout Relief 3310A Plus | 85631-009 | Tablet | Unapproved homeopathic products | September 5, 2025 |
| Sugar Control | 85631-008 | Tablet | Unapproved homeopathic products | September 4, 2025 |
| Gout Relief 3310-S | 85631-006 | Capsule | Unapproved homeopathic products | September 1, 2025 |
| Compound oyster peptide | 85631-004 | Capsule | Unapproved homeopathic products | August 3, 2025 |
| Gout Relief 3310-S | 85631-003 | Capsule | Unapproved homeopathic products | July 28, 2025 |
| Bispit Canada Ltd. | 85631-002 | Tablet | Unapproved homeopathic products | June 5, 2025 |
| Gout Relief 3310-S | 85631-001 | Capsule | Unapproved homeopathic products | May 6, 2025 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.